CHEK1 and endometrial cancer: Lewis et al. [133] found that ATR mutations negatively regulated ATR-dependent CHK1 activation and cell cycle arrest after DNA damage, and in ATR-mutated endometrial cancer, ATR-dependent DDR response was inactivated, indicating that ATR mutations play an important role in MSI endometrial cancer.